Red Cross Advanced Life Support (ALS) Practice Exam

In cases of cardiac arrest where amiodarone is indicated, the subsequent dose after the initial administration is 150 mg. This is especially relevant in situations where the patient remains in a persistent shockable rhythm, such as ventricular fibrillation or pulseless ventricular tachycardia. The rationale behind this dosing is to reinforce the antiarrhythmic effects required to stabilize the patient's heart rhythm and improve the chances of successful resuscitation. The initial dose of amiodarone during cardiac arrest is typically 300 mg, and it is administered as a first-line treatment for these life-threatening arrhythmias. If the desired outcome is not achieved, medical guidelines recommend repeating the dose, but at a reduced amount of 150 mg for subsequent attempts. This approach is designed to provide an effective yet safe level of medication, minimizing potential side effects while maximizing therapeutic benefit. Rescuers and healthcare providers must follow established guidelines for dosing in emergency situations to ensure effective treatment and adherence to best practices in Advanced Life Support.